Composition including naphthoquinone compound for treating and preventing hearing loss
KR20100090676A
Uridine and uridine derivatives of enhancing biosynthesis of hyaluronic acid, glycosaminoglycan and/or collagen
KR20110062313A
Pharmaceutical composition comprising cytidine
KR20110062315A
Pharmaceutical composition comprising inosine or guanosine
KR20100054098A
Pharmaceutical composition for the treatment and prevention of cardiac diseases caused by ischemia or ischemic reperfusion
US2009124680A1
Use of prodrug composition containing naphthoquinone-based compound for manufacture of medicament for treatment or prevention of diseases involving metabolic syndrome
CN101820873A
Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
WO2010005123A1
Composition for enhancing biosynthesis of hyaluronic acid or glycosaminoglycan comprising orotic acid, a salt thereof, or a derivative thereof
KR20080099174A
Naphthoquinone-based pharmaceutical composition for treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
KR20080096419A
Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
KR20090073381A
Pharmaceutical composition for the treatment and prevention of cardiac disease
KR20090071829A
Pharmaceutical composition for treatment and prevention of kidney diseases
KR20090068476A
Pharmaceutical composition for the treatment and prevention of glaucoma
KR20090019654A
Method for prediction of reactivity to nqo1-activating agents using nqo1 polymorphism
EP2040756A1
Composition containing metal-acidic amino acid chelate accelerating absorption of metal
KR20080094466A
Pharmaceutical composition for treatment of metabolic syndrome
